Classical Hodgkin Lymphoma

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS withdrawal · 2024-03-20
Clinical Trial Update: A Trial Comparing Chemotherapy Versus Novel Immune Checkpoint Inhibitor (Pembrolizumab) Plus Chemotherapy in Treating Relapsed/Refractory Classical Hodgkin Lymphoma [Phase 3]
A Phase 3 trial comparing chemotherapy alone versus pembrolizumab plus chemotherapy in relapsed/refractory classical Hodgkin lymphoma has be…